Sermorelin
Approved medicineThe FDA has approved a version of this as a medicine, so it has been through large studies in people.
Also called GRF 1-29 / Geref / Sermorelin acetate
A shortened copy of a natural hormone that tells the body to make growth hormone. Doctors can prescribe it.
Can a doctor prescribe this?
Yes. Pharmacies are allowed to make it, so a doctor can write a prescription for it.
The FDA has not approved this as a medicine.
Was FDA-approved as Geref; the brand was discontinued. Pharmacies can still compound it with a prescription.
Official status: On the 503A bulks list. Checked 2024-09-27.
Lab suppliers we list: 13
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
No dosing information has been published in the research indexed here.
- Advances in the detection of growth hormone releasing hormone synthetic analogs.
Lab dish study
Drug testing and analysis · 2021
- Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.
Lab dish study
Analytical and bioanalytical chemistry · 2016
- Evaluation of Research Grade Peptides Marketed Directly to Consumers Reveals Extensive Variability in Purity and Measured Abundance
Journal not recorded · 2026
- A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.
The Journal of sports medicine and physical fitness · 2026
- Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report.
Frontiers in surgery · 2026
- Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Journal of pharmaceutical and biomedical analysis · 2026
- Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.
Journal of mass spectrometry : JMS · 2024
- Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.
Analytical biochemistry · 2023
- Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis.
Electrophoresis · 2023
- In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.
Biomedical chromatography : BMC · 2023
- Probing for peptidic drugs (2-10 kDa) in doping control blood samples.
Analytical science advances · 2022
- An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.
Journal of pharmaceutical and biomedical analysis · 2022
- A potentially effective drug for patients with recurrent glioma: sermorelin.
Annals of translational medicine · 2021
- Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.
Journal of chromatography. A · 2020
- Glycine-modified growth hormone secretagogues identified in seized doping material.
Drug testing and analysis · 2019
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Review of earlier work
Sports medicine (Auckland, N.Z.) · 2026
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Review of earlier work
Journal not recorded · 2026
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Review of earlier work
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
Review of earlier work
Frontiers in endocrinology · 2026
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Review of earlier work
Journal not recorded · 2025
- Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.
Review of earlier work
Translational andrology and urology · 2020